Irene L. Ibañez

Phosphorylation and Subcellular Localization of p27Kip1 Regulated by Hydrogen Peroxide Modulation in Cancer Cells

Irene L. Ibañez, C. Bracalente, C. Notcovich, 2012, PloS one.

H2O2 scavenging inhibits G1/S transition by increasing nuclear levels of p27KIP1.

Irene L. Ibañez, C. Bracalente, Ivanna Tropper, 2011, Cancer letters.

Induction and rejoining of DNA double strand breaks assessed by H2AX phosphorylation in melanoma cells irradiated with proton and lithium beams.

Irene L. Ibañez, C. Bracalente, B. Molinari, 2009, International journal of radiation oncology, biology, physics.

Evaluation of cell behavior on modified polypropylene with swift heavy ion irradiation

Irene L. Ibañez, H. Durán, R. Mazzei, 2012 .

Studies of endothelial monolayer formation on irradiated poly-l-lactide acid with ions of different stopping power and velocity

M. Behar, Irene L. Ibañez, M. Grasselli, 2015 .

Suppression of cancer growth by nonviral gene therapy based on a novel reactive oxygen species-responsive promoter.

O. Podhajcer, V. Gottifredi, G. Soria, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Induction and persistence of large γH2AX foci by high linear energy transfer radiation in DNA-dependent protein kinase-deficient cells.

Irene L. Ibañez, C. Bracalente, B. Molinari, 2013, International journal of radiation oncology, biology, physics.

3-O-Methylquercetin from Achyrocline satureioides—cytotoxic activity against A375-derived human melanoma cell lines and its incorporation into cyclodextrins-hydrogels for topical administration

F. Klamt, F. Figueiró, Irene L. Ibañez, 2021, Drug Delivery and Translational Research.

Reactive Oxygen Species in the Biology of Melanoma

Irene L. Ibañez, C. Notcovich, L. Policastro, 2011 .

Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Upregulation of antioxidant genes correlates with regression of melanoma malignancy and with malignant progression when downregulated

F. Klamt, Irene L. Ibañez, C. Bracalente, 2016, Oncotarget.